Evidence map›Paper›PMID 26787715›Full record

ReviewInfection and immunity2016

Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity.

Raymond M Johnson, Robert C Brunham

Abstract readReview
In one paragraph

Review in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. CXCR6 marks polyfunctional effector CD4 T cells required for anti-bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. UnveilingiScience · 2025
    Article
  4. Review
  5. Viral Vector-BasedVaccines · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Circulating immunity protects the female reproductive tract fromProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Raymond M JohnsonSection of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Robert C BrunhamVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, Canada robert.brunham@bccdc.ca.

Funding

Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infectionsR01AI113103 · NIAID · YALE UNIVERSITY · PI BRUNHAM, ROBERT CONRAD, JOHNSON, RAYMOND MORRIS · 2014 to 2018
$1.9M
NIAID NIH HHS R01 AI113103
6 · The paper itself

Abstract

For almost 2 decades, results from Chlamydia pathogenesis investigations have been conceptualized using a cytokine polarization narrative. Recent viral immunity studies identifying protective tissue-resident memory T cells (Trm) suggest an alternative paradigm based on localized immune networks. As Chlamydia vaccines enter the preclinical pipeline and, in the case of an attenuated trachoma vaccine, are given to human subjects, it may be useful to ask whether cytokine polarization is the appropriate framework for understanding and evaluating vaccine efficacy. In this review, we revisit C. trachomatis pathogenesis data from mice and humans using a Trm narrative and note a comfortable concordance with the Chlamydia pathogenesis literature.

Indexed as

AnimalsBacterial VaccinesChlamydiaChlamydia InfectionsHumansT-LymphocytesBacterial Vaccines

Identifiers

PMID26787715
PMCPMC4807466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.